FDA Adverse Event Injury Summary report: N

1064NM ND: YAG LASER

MDR report key: 2210563 · Received August 10, 2011

Report

Report Number
2954354-2011-00012
Event Type
Injury
Date Received
August 10, 2011
Date of Event
July 14, 2011
Report Date
August 10, 2011
Manufacturer
CUTERA
Product Code
GEX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE FOLLOWING INFORMATION WAS PROVIDED BY THE PATIENT AFTER EVALUATION BY THE TREATMENT PROVIDER. "PUZZLING ATROPHIC MACULES WITH ONSET 4 WEEKS FOLLOWING 1064NM LASER TREATMENT; WITH NO PRECEDING INFLAMMATORY PROCESS IN THE IMMEDIATE POST-TREATMENT PERIOD OR IMMEDIATELY PRECEDING THE FIRST OBSERVATION OF THE LESIONS. THE MECHANISM OR EXPLANATION FOR THESE IS NOT CLEAR. THE LESION ON THE LEFT CHEEK AND THE RESOLVED AREA OVER THE NASAL DORSUM HAVE A TIME COURSE THAT COULD BE RELATED TO THE LASER; THESE CONTINUE TO RESOLVE WELL. ALL LESIONS ARE EXPECTED TO IMPROVE WITH THE TINCTURE OF TIME AND I WOULD RECOMMEND NO INTERVENTION FOR AT LEAST 6 MONTHS. IMPROVEMENTS MAY CONTINUE UP TO 1 YEAR. IF ATROPHY DOES PERSIST CONSIDER THE USE OF HA FILLER OR CONSERVATIVE RESURFACING OR NONABLATIVE REMODELING." LATE ENTRY: PATIENT TELEPHONED TO REPORT SHE HAD SEEN HER PLASTIC SURGEON THAT DIAGNOSED: "SCAR FROM COLLAGEN CONTRACTION."

Description of Event or Problem · 1

"ATROPHIC MACULES WITH ONSET 4 WEEKS FOLLOWING 1064NM LASER TREATMENT - LEFT CHEEK AND X 2 ON THE NOSE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 1064NM ND: YAG LASER 1064NM ND: YAG LASER GEX CUTERA

Patients

Seq Age Sex Outcome Treatment
1 45 YR Other RETIN-A MICRO 0.1% CREAM| MINOCYLINE 100 MG| 15MSEC, 56 PULSES / LASER GENESIS: 15J/CM2| CLINDAMYCIN 1% LOTION| BENZOYL PEROXIDE| NORITATE CREAM| LASER VASCULAR TREATMENT: 3MM SPOT, 160J/CM2,